BioCentury | Jul 20, 2015
Emerging Company Profile
Shot in the DYRK
...help screen for quiescence targets and molecules. Companies and Institutions Mentioned Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc....
...al. "Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells." Molecular Cancer Therapeutics (2011) Sidebars Felicitex Therapeutics Inc....
...al. "Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells." Molecular Cancer Therapeutics (2011) Sidebars Felicitex Therapeutics Inc....
